65 related articles for article (PubMed ID: 35214646)
1. Changes in HPV16/18 Prevalence among Unvaccinated Women with Cervical Intraepithelial Neoplasia in Japan: Assessment of Herd Effects following the HPV Vaccination Program.
Onuki M; Yamamoto K; Yahata H; Kanao H; Horie K; Konnai K; Nio A; Takehara K; Kamiura S; Tsuda N; Takei Y; Shigeta S; Nakai H; Yoshida H; Motohara T; Kato T; Nakamura K; Hamanishi J; Tasaka N; Ishikawa M; Kado N; Taira Y; Mori M; Iwata T; Takahashi F; Kukimoto I; Yoshikawa H; Yaegashi N; Matsumoto K; For The Mint Study Group
Vaccines (Basel); 2022 Jan; 10(2):. PubMed ID: 35214646
[TBL] [Abstract][Full Text] [Related]
2. Reduction in HPV16/18 prevalence among young women with high-grade cervical lesions following the Japanese HPV vaccination program.
Matsumoto K; Yaegashi N; Iwata T; Yamamoto K; Aoki Y; Okadome M; Ushijima K; Kamiura S; Takehara K; Horie K; Tasaka N; Sonoda K; Takei Y; Aoki Y; Konnai K; Katabuchi H; Nakamura K; Ishikawa M; Watari H; Yoshida H; Matsumura N; Nakai H; Shigeta S; Takahashi F; Noda K; Yoshikawa H;
Cancer Sci; 2019 Dec; 110(12):3811-3820. PubMed ID: 31596999
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus genotype contribution to cervical cancer and precancer: Implications for screening and vaccination in Japan.
Onuki M; Matsumoto K; Iwata T; Yamamoto K; Aoki Y; Maenohara S; Tsuda N; Kamiura S; Takehara K; Horie K; Tasaka N; Yahata H; Takei Y; Aoki Y; Kato H; Motohara T; Nakamura K; Ishikawa M; Kato T; Yoshida H; Matsumura N; Nakai H; Shigeta S; Takahashi F; Noda K; Yaegashi N; Yoshikawa H
Cancer Sci; 2020 Jul; 111(7):2546-2557. PubMed ID: 32372453
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus vaccine effectiveness by age at first vaccination among Japanese women.
Onuki M; Yamamoto K; Yahata H; Kanao H; Yokota H; Kato H; Shimamoto K; Takehara K; Kamiura S; Tsuda N; Takei Y; Shigeta S; Matsumura N; Yoshida H; Motohara T; Watari H; Nakamura K; Ueda A; Tasaka N; Ishikawa M; Hirashima Y; Kudaka W; Taguchi A; Iwata T; Takahashi F; Kukimoto I; Yoshikawa H; Yaegashi N; Matsumoto K;
Cancer Sci; 2022 Apr; 113(4):1428-1434. PubMed ID: 35043515
[TBL] [Abstract][Full Text] [Related]
5. HPV type-specific trends in cervical precancers in the United States, 2008 to 2016.
Gargano JW; McClung N; Lewis RM; Park IU; Whitney E; Castilho JL; Pemmaraju M; Niccolai LM; Brackney M; DeBess E; Ehlers S; Bennett NM; Scahill M; Cleveland AA; Querec TD; Unger ER; Markowitz LE;
Int J Cancer; 2023 Jan; 152(2):137-150. PubMed ID: 35904861
[TBL] [Abstract][Full Text] [Related]
6. HPV16/18 prevalence in high-grade cervical lesions in an Australian population offered catch-up HPV vaccination.
Cornall AM; Saville M; Pyman J; Callegari ET; Tan FH; Brotherton JML; Malloy MJ; Tabrizi SN; Wrede CD; Garland SM;
Vaccine; 2020 Sep; 38(40):6304-6311. PubMed ID: 32736938
[TBL] [Abstract][Full Text] [Related]
7. Assessment of herd effects among women and heterosexual men after girls-only HPV16/18 vaccination in the Netherlands: A repeated cross-sectional study.
Woestenberg PJ; Bogaards JA; King AJ; Leussink S; van der Sande MA; Hoebe CJ; van Benthem BH;
Int J Cancer; 2019 Jun; 144(11):2718-2727. PubMed ID: 30426502
[TBL] [Abstract][Full Text] [Related]
8. Human Papillomavirus Distribution in Women with Abnormal Pap Smear and/or Cervical Intraepithelial Neoplasia in Vaccination Era. A Single-Center Study in the North Italian Population.
Gardella B; Dominoni M; Sosso C; Arrigo A; Gritti A; Cesari S; Fiandrino G; Spinillo A
Microorganisms; 2021 Mar; 9(4):. PubMed ID: 33807458
[TBL] [Abstract][Full Text] [Related]
9. The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years.
Brown DR; Kjaer SK; Sigurdsson K; Iversen OE; Hernandez-Avila M; Wheeler CM; Perez G; Koutsky LA; Tay EH; Garcia P; Ault KA; Garland SM; Leodolter S; Olsson SE; Tang GW; Ferris DG; Paavonen J; Steben M; Bosch FX; Dillner J; Joura EA; Kurman RJ; Majewski S; Muñoz N; Myers ER; Villa LL; Taddeo FJ; Roberts C; Tadesse A; Bryan J; Lupinacci LC; Giacoletti KE; Sings HL; James M; Hesley TM; Barr E
J Infect Dis; 2009 Apr; 199(7):926-35. PubMed ID: 19236279
[TBL] [Abstract][Full Text] [Related]
10. Trend of HPV 16/18 Genotypes in Cervical Intraepithelial Neoplasia Grade 3: Data for 2007-2018.
Giannella L; Delli Carpini G; Di Giuseppe J; Bogani G; Gardella B; Monti E; Liverani CA; Ghelardi A; Insinga S; Montanari M; Raspagliesi F; Spinillo A; Vercellini P; Roncella E; Ciavattini A
Infect Drug Resist; 2021; 14():3763-3771. PubMed ID: 34557001
[TBL] [Abstract][Full Text] [Related]
11. Reduction in HPV 16/18 prevalence among young women following HPV vaccine introduction in a highly vaccinated district, Japan, 2008-2017.
Karube A; Saito F; Nakamura E; Shitara A; Ono N; Konno M; Tamura D; Nagao D
J Rural Med; 2019 May; 14(1):48-57. PubMed ID: 31191766
[No Abstract] [Full Text] [Related]
12. Human papillomavirus types in cervical high-grade lesions or cancer among Nordic women-Potential for prevention.
Dovey de la Cour C; Guleria S; Nygård M; Trygvadóttir L; Sigurdsson K; Liaw KL; Hortlund M; Lagheden C; Hansen BT; Munk C; Dillner J; Kjaer SK
Cancer Med; 2019 Feb; 8(2):839-849. PubMed ID: 30632704
[TBL] [Abstract][Full Text] [Related]
13. Projected impact of Cervarix® vaccination on oncogenic human papillomavirus infection and cervical cancer in the United Kingdom.
Van Effelterre T; Hogea C; Taylor S
Hum Vaccin Immunother; 2014; 10(7):1794. PubMed ID: 25424784
[TBL] [Abstract][Full Text] [Related]
14. Changes in Cervical Human Papillomavirus (HPV) Prevalence at a Youth Clinic in Stockholm, Sweden, a Decade After the Introduction of the HPV Vaccine.
Ährlund-Richter A; Cheng L; Hu YOO; Svensson M; Pennhag AAL; Ursu RG; Haeggblom L; Grün N; Ramqvist T; Engstrand L; Dalianis T; Du J
Front Cell Infect Microbiol; 2019; 9():59. PubMed ID: 30949454
[No Abstract] [Full Text] [Related]
15. Impact of human papillomavirus types on uterine cervical neoplasia.
Taguchi A; Yoshimoto D; Kusakabe M; Baba S; Kawata A; Miyamoto Y; Mori M; Sone K; Hirota Y; Osuga Y
J Obstet Gynaecol Res; 2024 Jun; ():. PubMed ID: 38852606
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of human papillomavirus vaccination in young Japanese women: a retrospective multi-municipality study.
Tozawa-Ono A; Kamada M; Teramoto K; Hareyama H; Kodama S; Kasai T; Iwanari O; Koizumi T; Ozawa N; Suzuki M; Kinoshita K
Hum Vaccin Immunother; 2021 Apr; 17(4):950-954. PubMed ID: 33121340
[TBL] [Abstract][Full Text] [Related]
17. Quadrivalent HPV vaccine effectiveness against high-grade cervical lesions by age at vaccination: A population-based study.
Herweijer E; Sundström K; Ploner A; Uhnoo I; Sparén P; Arnheim-Dahlström L
Int J Cancer; 2016 Jun; 138(12):2867-74. PubMed ID: 26856527
[TBL] [Abstract][Full Text] [Related]
18. Association between Vaginal Micro-environment Disorder and Cervical Intraepithelial Neoplasia in a Community Based Population in China.
Li L; Ding L; Gao T; Lyu Y; Wang M; Song L; Li X; Gao W; Han Y; Jia H; Wang J
J Cancer; 2020; 11(2):284-291. PubMed ID: 31897224
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus genotype-specific prevalence across the continuum of cervical neoplasia and cancer.
Joste NE; Ronnett BM; Hunt WC; Pearse A; Langsfeld E; Leete T; Jaramillo M; Stoler MH; Castle PE; Wheeler CM;
Cancer Epidemiol Biomarkers Prev; 2015 Jan; 24(1):230-40. PubMed ID: 25363635
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and genotype distribution of human papillomavirus in women with cervical cancer or cervical intraepithelial neoplasia in Henan province, central China.
Chen G; Zheng P; Gao L; Zhao J; Wang Y; Qin W
J Med Virol; 2020 Dec; 92(12):3743-3749. PubMed ID: 31930525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
